Effects of biliary obstruction on the penetration of ciprofloxacin and cefotaxime

European Journal of Gastroenterology and Hepatology

Volumn 20, Issue 2, 2008, Pages 127-130

  Dhalluin Venier, Valérie ^a,d   Bazin, Christophe ^b   Massias, Laurent ^c   Farah, Rita Bou ^a   Boytchev, Isabelle ^a   Fritsch, Jacques ^a   Choury, André Daniel ^a   Prat, Frédéric ^a   Buffet, Catherine ^a   Furlan, Valérie ^b   Pelletier, Gilles ^a  

^a Hepatology   (France)

^b BICÊTRE HOSPITAL   (France)

^c BICHAT HOSPITAL   (France)

^d NONE   (France)

Author keywords

Biliary diffusion; Biliary tract obstruction; Cefotaxime; Ciprofloxacin; Endoscopic retrograde cholangiopancreatography

Indexed keywords

ALKALINE PHOSPHATASE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; BILIRUBIN; CEFOTAXIME; CEPHALOSPORIN; CIPROFLOXACIN; GAMMA GLUTAMYLTRANSFERASE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UREIDOPENICILLIN;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BILE DUCT OBSTRUCTION; BILIARY TRACT DRAINAGE; BILIARY TRACT INFECTION; BILIRUBIN BLOOD LEVEL; DRUG BILE LEVEL; DRUG BLOOD LEVEL; DRUG DIFFUSION; DRUG PENETRATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BILE; BILIRUBIN; CEFOTAXIME; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLANGITIS; CHOLESTASIS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIPROFLOXACIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 38049155919     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3282f1c985     Document Type: Article

References (21)

1. Westphal JF, Brogard LM. Biliary tract infections. A guide to drug treatment. Drugs 1999; 57:81-91.
2. Dooley JS, Hamilton-Miller JM, Brumfitt W, Sherlok S. Antibiotics in the treatment of biliary infection. Gut 1984; 25:988-998.
3. Parry MF, Smego DA, Digiovanni MA. Hepatobiliary kinetics and excretion of ciprofloxacin. Antimicrob Agents Chemother 1988; 32:982-985.
4. Vance-Bryan K, Guay DR, Rotschafer JC. Clinical pharmacokinetics of ciprofloxacin. Clin Pharmacokinet 1990; 19:434-461.
5. Soussy CJ, Deforges LP, Le Van Thoi J, Feghali W, Daval JR. Cefotaxime concentration in the bile and wall of the gallbladder. J Antimicrob Chemother 1980; 6:125-130.
6. Jehl F, Peter JD, Picard A, Dupeyron JP, Marescaux J, Sibilly A, et al. Biliary excretion of cefotaxime and desacetylcefotaxime. Rev Med Interne 1987; 8:487-492.
7. Kees F, Strehl E, Dominiak P, Grobecker H, Seeger K, Seidel G, et al. Cefotaxime and desacetylcefotaxime in human bile. Infection 1983; 11:118-120.
8. Leung JW, Ling TK, Chan RC, Cheung SW, Lai CW, Sung JJ, et al. Antibiotics, biliary sepsis, and bile duct stones. Gastrointest Endosc 1994; 40:716-721.
9. Chen CY, Shiesh SC,Wu MC, Lin SZ. The effects of bile duct obstruction on the biliary secretion of ciprofloxacin in piglets. Am J Gastroenterol 1999; 94:2408-2411.
10. Van den Hazel SJ, de Vries XH, Speelman P, Dankert J, Tytgat JN, Huibregtse K, et al. Biliary excretion of ciprofloxacin and piperacillin in the obstructed biliary tract. Antimicrob Agents Chemother 1996; 40:2658-2660.
11. Fu KP, Aswapokee P, Ho I, Matthijssen C, Neu HC. Pharmacokinetics of cefotaxime. Antimicrob Agents Chemother 1979; 16:592-597.
12. Wise R, Lockley RM,Webberly M, Dent J. Pharmacokinetics of intravenously administered ciprofloxacin. Antimicrob Agents Chemother 1984; 26:208-210.
13. Vallée F, LeBel M. Comparative study of pharmacokinetics and serum bactericidal activity of ceftizoxime and cefotaxime. Antimicrob Agents Chemother 1991; 35:2057-2064.
14. Paradis D, Vallée F, Allard S, Bisson C, Daviau N, Drapeau C, et al.. Comparative study of pharmacokinetics and serum bactericidal activities of cefpirome, ceftazidime, ceftriaxone, imipenem and ciprofloxacin. Antimicrob Agents Chemother 1992; 36:2085-2092.
15. Giuseppe C. Analysis of fluoroquinolones in biological fluids by high-performance liquid chromatography. J Chromatogr A 1998; 812:343-367.
16. Evans WE, Schentag JJ, Jusko WJ, Relling MV. Applied pharmacokinetics. Principles of therapeutic drug monitoring. 3rd ed. Vancouver, WA: Applied Therapeutics Inc; 1992.
17. Krausse R, Ullmann U, Brandstetter G, Kratochvil P. Investigation of human bile and serum levels by high pressure liquid chromatography after administration of latamoxef or cefotaxime. Arzneim Forsch drug Res 1984; 34:1787-1791.
18. Van den Hazel SJ, Speelman P, Tytgat GN, van Leeuwen DJ. Successful treatment of recurrent cholangitis with antibiotic maintenance therapy. Eur J Gastroenterol Hepatol 1994; 6:1053-1057.
19. Hanau LH, Steigbigel NH. Acute (ascending) cholangitis. Infectious Dis Clinics North America 2000; 14:521-527.
20. Labaune JP. Liver clearance. Pharmacokinetic: basic principles [in French]. Paris: Masson; 1984. pp. 175-205.
21. Lai EC, Mok FP, Tan ES, Lo CM, Fan ST, You KT, et al. Endoscopic biliary drainage for severe acute cholangitis. N Eng J Med 1992; 326:1582-1586.